RecruitingNCT00707694

The Longevity Genes in Founder Populations Project

Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population

Sponsor

Albert Einstein College of Medicine

Enrollment

2,000 participants

Start Date

Jul 1, 1998

Study Type

OBSERVATIONAL

Conditions

Extreme Longevity

Summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with extreme longevity. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

Private Homes

New York, New York, United States

Hebrew Home Riverdale

Riverdale, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00707694

Related Trials

Longevity Families of the Netherlands

NCT063740691 location